Screen Shot 2017-03-03 at 8.46.46 PM.png

Adoneca Fortier

Board Member

Adoneca Fortier was the former Supervisor of Clinical Studies at MD Anderson Cancer Center in the Department of Investigational Cancer Therapeutics.  She has been a cancer researcher over 20 years, and she is married with one son.  

Originally from Louisiana growing up in both Baton Rouge and New Orleans.  She attended Louisiana State University (LSU) and the University of New Orleans (UNO). After graduation, she moved to Houston to become part of the best rated medical center in the world. She is also a Certified Clinical Research Professional who before settling into the world of oncology, worked in Behavioral Science research over 10 years. Along with a background in psychology, psychopharmacology, and cancer research, another passion in her life is to motivate young girls to consider a career in science and politics. She often travels and speaks on career opportunities for women in medicine and science.

She currently sits on the LSU (Houston) Alumni Board of Directors, is a member of National Federation of Democratic Women, and is a proud active member of Alpha Sigma Alpha sorority, where she is a former Board of Trustee with the Alpha Sigma Alpha Foundation.  Politically, she serves as Precinct Chair (264) in Senate District 15 and serves on the Harris County Finance Committee.  Adoneca is also a member of Spring Branch Democrats and Texas Democratic Women of Harris County. She is the newly elected secretary with Spring Branch Democrats and co-chair the Texas Democratic Women Legislative committee.

Adoneca believes in giving back to the community and paying it forward. Her community leadership and philanthropy activities include being lead Ambassador and lobbyist for American Cancer Society Cancer Network. “I'm very proud to have been a part of lobbying for Joe Biden's cancer moonshot which helped pass a 6.3 billion dollar research bill,” said Adoneca, “I'm now looking forward to working on 2017 Legislative priorities such as access to healthcare, more cancer research and tobacco bills.”